Fact CheckerSign in

NCT05725967Enrolling by invitation

Endoscopic Metabolic and Bariatric Therapies

Source: ClinicalTrials.gov · Last updated 2 Dec 2025

Brief summary (registry, in English)

This is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
5000 (estimated)
First submitted
29 Dec 2022
Start date
8 Jul 2022
Primary completion date
28 May 2028
Lead sponsor
Christopher C. Thompson, MD, MSc
Diseases
Obesity
NCT number
NCT05725967

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 8 Jul 2022 to the primary completion date, 28 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • patients without past surgical and medical history medical records in the Mass General Brigham system

Other

  • patients unwilling to allow for medical record review at Mass General Brigham

Who the study is looking for

  • patients from Mass General Brigham
  • any patient having an endoscopic primary obesity procedure
  • any patient having an endoscopic post-bariatric surgical revision procedure
  • any patient having a bariatric surgical procedure

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.